文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

无创呼吸支持策略对急性低氧性呼吸衰竭成人生理效应的影响:系统评价与网状Meta分析

Physiological effects of noninvasive respiratory support strategies in adults with acute hypoxemic respiratory failure: a systematic review and network meta-analysis.
PubMed 文献 · Crit Care · 2025-10-28
一句话结论HFNO与NIV降低每分钟吸气努力,仅NIV降低每次吸气努力但升高驱动压;CPAP对驱动压与努力无影响;CPAP与NIV改善氧合优于HFNO。

该系统评价与网状Meta分析纳入13项生理学研究(n=312例急性低氧性呼吸衰竭成人,平均PaO2/FiO2=131±48 mmHg,平均呼吸频率=28±8次/分),比较标准氧疗、HFNO、NIV与CPAP对跨肺驱动压和吸气努力的影响。与标准氧疗相比,HFNO和CPAP不影响跨肺驱动压或每次吸气努力;HFNO和NIV降低每分钟吸气努力(分别为-95 cmH2O·bpm和-240 cmH2O·bpm),CPAP无此效应;NIV降低每次吸气努力(-5.9 cmH2O)但升高驱动压(3.4 cmH2O)。所有策略均降低呼吸频率(HFNO降幅最大,-5次/分),均改善PaO2/FiO2(CPAP与NIV效果大于HFNO),均不影响PaCO2。作者认为,基于吸气努力水平个体化选择可能有助于平衡无创支持的获益与风险。

要点

  • NIV降低每次吸气努力(-5.9 cmH2O)但升高跨肺驱动压(3.4 cmH2O),提示NIV可能增加肺损伤风险。
  • HFNO和NIV降低每分钟吸气努力(分别为-95 cmH2O·bpm和-240 cmH2O·bpm),CPAP无此效应。
  • CPAP对跨肺驱动压和吸气努力均无影响,但改善氧合效果优于HFNO(PaO2/FiO2 +67 mmHg vs +24 mmHg)。
  • NIV改善氧合效果大于HFNO(PaO2/FiO2 +82 mmHg vs +24 mmHg)。
  • 所有无创策略均降低呼吸频率,HFNO降幅最大(-5次/分),均不影响PaCO2。

适用人群与场景

  • 急性低氧性呼吸衰竭成人,平均PaO2/FiO2=131±48 mmHg,平均呼吸频率=28±8次/分。
  • 纳入研究为评估至少两种无创呼吸支持策略下食管测压吸气努力的生理学研究。

研究设计与关键结果

  • 系统评价与网状Meta分析纳入13项生理学研究,共312例患者,检索截至2025年2月16日。
  • 与标准氧疗相比,HFNO和CPAP不影响跨肺驱动压或每次吸气努力;HFNO降低每分钟吸气努力-95 cmH2O·bpm(95%CI -140至-49),NIV降低-240 cmH2O·bpm(95%CI -284至-196),CPAP无此效应。
  • NIV降低每次吸气努力-5.9 cmH2O(95%CI -7.4至-4.4)但升高跨肺驱动压3.4 cmH2O(95%CI 1.4至5.4)。
  • 所有策略均降低呼吸频率:HFNO -5次/分(95%CI -6至-4),CPAP -2次/分(95%CI -4至-1),NIV -4次/分(95%CI -5至-2)。
  • 所有策略均改善PaO2/FiO2:CPAP +67 mmHg(95%CI 55至80),NIV +82 mmHg(95%CI 56至108),HFNO +24 mmHg(95%CI 5至43);CPAP和NIV效果大于HFNO。
  • 所有策略均不影响PaCO2。

证据类型、等级与局限

  • 证据类型:系统评价与网状Meta分析,纳入13项生理学研究(n=312)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,基于吸气努力水平个体化选择无创呼吸支持策略可能有助于平衡获益与风险。
  • NIV虽降低每次吸气努力但升高跨肺驱动压,HFNO和NIV降低每分钟吸气努力,CPAP对驱动压和努力无影响,选择策略时需考虑这些生理效应差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: In hypoxemic patients, the respective effects of noninvasive respiratory support strategies on lung injury determinants remain unclear, primarily due to the difficulty of obtaining standardized measurements for all interventions within the same study. We conducted a systematic review and network meta-analysis to assess the effects of noninvasive strategies on transpulmonary driving pressure and inspiratory effort in patients with acute hypoxemic respiratory failure.

METHODS: We conducted a systematic search (Ovid MEDLINE, Embase, Scopus, and PubMed) and performed a network meta-analysis of physiological studies involving hypoxemic adults published up to February 16th, 2025. We included studies that assessed inspiratory effort with esophageal manometry under at least two noninvasive respiratory support strategies [standard oxygen, high-flow nasal oxygen (HFNO), noninvasive ventilation (NIV), and continuous positive airway pressure (CPAP)]. Outcomes included transpulmonary driving pressure, inspiratory effort per breath and per minute, respiratory rate, and gas exchange. Treatment effects are displayed as mean differences [95% confidence intervals].

RESULTS: Among 5876 citations, thirteen studies (n = 312 patients) were included (mean PaO2/FiO2 = 131 (± 48) mmHg, mean respiratory rate = 28 (± 8) breaths*min-1). Compared to standard oxygen, HFNO and CPAP did not affect transpulmonary driving pressure or effort per breath. HFNO and NIV reduced effort per minute (-95 cmH2O*bpm [-140; -49] and -240 cmH2O*bpm [-284; -196], respectively), whereas CPAP did not. NIV lowered effort per breath (-5.9 cmH2O [-7.4; -4.4]) but increased driving pressure (3.4 cmH₂O [1.4; 5.4]). All strategies reduced respiratory rate, with HFNO producing the greatest decrease (HFNO: -5 breaths*min-1 [-6; -4]; CPAP: -2 breaths*min-1 [-4; -1]; NIV: -4 breaths*min-1 [-5; -2]); all interventions improved PaO2/FiO2, with CPAP and NIV showing greater effects than HFNO (CPAP: 67 mmHg [55; 80]; NIV: 82 mmHg [56; 108]; HFNO: 24 mmHg [5; 43]). None of the strategies affected PaCO2.

CONCLUSIONS: Noninvasive strategies exert distinct physiological effects: HFNO and NIV reduce effort per minute, while only NIV decreases effort per breath but at the cost of increased driving pressure. CPAP has neutral effects on driving pressure and effort. CPAP and NIV provide greater improvements in oxygenation than HFNO. Individualized selection based on effort levels may help balance the benefits and risks of noninvasive support.

PROSPERO REGISTRATION: CRD42024564035.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Menga LS, Balzani E, Gelormini C, et al. Physiological effects of noninvasive respiratory support strategies in adults with acute hypoxemic respiratory failure: a systematic review and network meta-analysis. Crit Care. 2025. PMID: 41152956. doi:10.1186/s13054-025-05670-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。